click below
click below
Normal Size Small Size show me how
Heiman.pharm.HTN
HTN concepts.physiology
Question | Answer |
---|---|
Prehypertension | SBP: 120-139 DBP: 80-89 Lifestyle modification needed No antihypertensive indicated |
Stage 1 Hypertension | SBP: 140-159 DBP: 90-99 Lifestyle modification needed. May consider ACE inhibitor, ARB, beta blocker, CCB, or combination |
Stage 2 hypertension | SBP: >160 or DBP: >100 Lifestyle modification needed 2 drug therapy for most (usually thiazide-type diuretic & ACE inhibitor or ARB or beta blocker, or CCB) |
Neuronal mechanisms of BP control:Peripheral nervous system | alpha and beta receptors. |
Neuronal mechanisms of BP control: Baroreceptor reflex | Nerve endings in the walls of large arteries. Feedback mechanism triggers vasodilation when BP increases acutely. These reflexes may be blunted in the elderly. |
Neuronal mechanisms of BP control: Central nervous system | Vagal nuclei, Vasomotor center. |
Neuronal mechanisms of BP control: Peripheral autoregulation | Renal:Changes in Na and water retention. Local tissue autoregulation: These processes are related to oxygen demand. |
Humoral mechanisms of BP control: | Renin-angiotensin-aldosterone: Regulation of Na, K, and fluid balance. Natriuretic hormone: Regulation of Na balance. |
Humoral mechanisms of BP control:cont'd | Hyperinsulinemia and insulin resistance. Possible increases in renal Na retention. Possible enhanced sympathetic nervous system activity. Growth hormone like activity. |
Lifestyle modifications: | Weight loss. Limit alcohol intake. Increase aerobic activity. Reduce Na intake to 2.4 G/d or less. Maintain dietary K, Ca, and Mg. Reduce intake of dietary saturated fat and cholesterol. Stop smoking. |
High risk with compelling indication: Heart failure | Diuretic. beta blocker. ACE inhibitor. ARB. Aldosoterone antagonist. |
High risk with compelling indication: Post myocardial infarction | Beta blocker. ACE inhibitor. Aldosterone antagonist. |
High risk with compelling indication: High coronary disease risk: | Diuretic. Beta blocker. ACE inhibitor. CCB. |
High risk with compelling indication:Diabetes | Diuretic. Beta blocker. ARB. ACE inhibitor. CCB. |
High risk with compelling indication: Chronic kidney disease | ACE inhibitor. ARB. |
High risk with compelling indication: Recurrent stroke prevention | Diuretic. ACE inhibitor. |
Special Populations: | Asthma, COPD, peripheral arterial disease; Avoid β-blockers. Elderly;Centrally acting agents and α-blockers are generally avoided Elderly are sensitive to sympathetic inhibition leading to postural hypotension. Start w/ low dose. |
Special populations: | Children: Secondary HTN more common. Pregnancy: Methlydopa (Aldomet) Labetalol (Trandate, Normodyne) ACE inhibitors and ARBs are contraindicated. |
Special Populations | African – American: May be more Na sensitive, more responsive to diuretic therapy, β-blockers, ACE inhibitors, and ARBs may not be as good for monotherapy. |
Diuretic Resistance | Ability of diuretic to increase NaCl excretion declines with time May need to add second drug Causes Patient noncompliance Impaired bioavailability Renal failure Drugs NSAIDS, captopril, cimetidine, antihypertensives |